Cynata Therapeutics Limited, a clinical-stage biotechnology company specializing in cell therapeutics, confirms that the first patient has been enrolled and treated in its phase 2 clinical trial of CYP-001 in high-risk acute graft versus
The owner of Sudeep Pharma is in talks with Avendus Capital to secure ₹800 crore in debt to buy out its joint venture partner, German manufacturer JRS Pharma, and take full ownership of the pharmaceutical company.
The Subject Expert Committee (SEC), which advises the national drug regulator on drug approvals and clinical trials, has recommended the grant of permission to drug major AstraZeneca for the import and marketing of two strengths of anti-hyperkalemia
Roche Pharma India has Introduced Vabysmo (faricimab) in the Indian market. This monoclonal immune response drug targets two critical reasons for vision impairment among the old and diabetic patients. In a proclamation...
Caliway Biopharmaceuticals declared that the US Food and Medication Organization (FDA) permitted Orphan Drug Designation (ODD) to CBL-514 for Dercum's illness treatment. CBL-514 is a lipolysis injection that can diminish nearby subcutaneous fat...
Sandoz, the leader in conventional and biosimilar drugs, has acquired the US biosimilar Cimerli (ranibizumab-eqrn) from Coherus BioSciences, Inc., before expected timetables. The procurement expands on the main Sandoz ophthalmic stage in the US...
Cadila Pharmaceuticals said it has introduced an immunization to prevent flu, a repetitive and far and wide viral infection. The medication firm has presented quadrivalent Cadiflu Tetra immunization, endorsed by the DCGI (Drugs Controller General...
Union Minister of Health and Family Welfare Dr Mansukh Mandaviya launched the Ayush-ICMR Advanced Centre for Integrated Health Research in AIIMS and announced other mega joint initiatives between the Health Ministry and the Ministry of Ayush.
The UK Government's Rare Disease Action Plan 2024 has been published, detailing what the NIHR, DHSC and others have done over the past year to better meet the needs of patients with rare diseases.
In a major move to improve the accuracy and accessibility of breast cancer screening in India, Indira IVF has partnered with BD SurePath.
, CDSCO.jpg)
.jpg)